title: Cytomegalovirus colitis in a patient treated with efalizumab.
authors.forename: Anne
authors.initials: A
authors.lastname: Caudron
authors.forename: Catherine
authors.initials: C
authors.lastname: Lok
authors.forename: Angèle
authors.initials: A
authors.lastname: Clabaut
authors.forename: Julien
authors.initials: J
authors.lastname: Desblache
authors.forename: Bertrand
authors.initials: B
authors.lastname: Heyman
authors.forename: Valérie
authors.initials: V
authors.lastname: Viseux
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D003092:Colitis / Q000276:immunology / Q000821:virology*; D003586:Cytomegalovirus Infections / Q000150:complications*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; C472181:efalizumab